EKF, Quest Diagnostics announce acquisition deals

03/13/2014 | Clinica (subscription required)

EKF Diagnostics hopes to widen its footprint in the hematology testing market with its $4 million purchase of Separation Technology, a Thermo Fisher Scientific unit. Separately, Quest Diagnostics has agreed to pay an undisclosed sum to buy Summit Health, its second acquisition this year, in a move that would expand its health and wellness portfolio.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX